Cochrane · systematic review · CD000323
Swallowing therapy for dysphagia in acute and subacute stroke
Bath, PM, Lee, HS, Everton, LF · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library
StrokeAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 2 · 28.6%Low 2 · 28.6%Moderate 3 · 42.9%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Swallowing therapy compared to placebo for dysphagia in acute and subacute stroke
Population: dysphagia in acute and subacute stroke
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Death or dependency at end of trial Swallowing therapy vs placebo | OR 1.05 [0.63, 1.75] | 2 studies · 306 participants | Moderate Downgraded: risk of bias, imprecision, inconsistency, indirectness |
Case fatality at end of trial Swallowing therapy vs placebo | OR 1 [0.66, 1.52] | 14 studies · 766 participants | Moderate Downgraded: risk of bias, imprecision, inconsistency, indirectness |
Length of inpatient stay (days) Swallowing therapy vs placebo | no estimate extracted | 8 studies · 577 participants | Moderate Downgraded: risk of bias, imprecision, inconsistency, indirectness |
Proportion of participants with dysphagia at end of trial Swallowing therapy vs placebo | OR 0.42 [0.32, 0.55] | 23 studies · 1487 participants | Low Downgraded: risk of bias, imprecision, inconsistency, indirectness |
Swallowing ability Swallowing therapy vs placebo | no estimate extracted | 26 studies · 1173 participants | Very low Downgraded: risk of bias, imprecision, inconsistency, indirectness |
Penetration aspiration score Swallowing therapy vs placebo | no estimate extracted | 11 studies · 303 participants | Low Downgraded: risk of bias, imprecision, inconsistency, indirectness |
Adverse event: chest infection or pneumonia Swallowing therapy vs placebo | OR 0.34 [0.17, 0.71] | 10 studies · 676 participants | Very low Downgraded: risk of bias, imprecision, inconsistency, indirectness |